[Treatment of a severely injured with active bleeding under apixaban and residual anticoagulatory activity]. / Schwerstverletztenversorgung mit aktiver Blutung unter Apixaban und gerinnungsrelevanter Restaktivität.

Direct oral anticoagulants (DOAC) are increasingly being prescribed for prophylaxis of thromboembolic events. Their use, particularly in emergency settings is difficult as blood level measurements are often not immediately available and until recently there was no possibility for reversal. This article presents the case of a severely injured patient with life-threatening traumatic bleeding under long-term treatment with the factor Xa inhibitor apixaban, viscoelasticity-based detection of residual systemic anticoagulatory activity and targeted reversal.